Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
H&R GmbH KGaALTS:0RRC 62 12-1 Month Momentum % is 18.79% as of Sep. 11, 2026. GuruFocus rates LTS:0RRC with a GF Score™ of 62/100 and a GF Value™ of €4.79 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,617 Chemicals companies, H&R GmbH KGaA ranks better than 72.29% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-09-11), H&R GmbH KGaA's 12-1 Month Momentum % is 18.79%.
The industry rank for H&R GmbH KGaA's 12-1 Month Momentum % or its related term are showing as below:
LTS:0RRC's 12-1 Month Momentum % is ranked better than 72.29% of 1617
companies
in the Chemicals industry
Industry Median: 0.32
vs LTS:0RRC: 18.79
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
H&R GmbH KGaA 12-1 Month Momentum % Related Terms
LTS:0RRC vs LIN, SHW, ECL: 12-1 Month Momentum % Comparison
For the Specialty Chemicals subindustry, H&R GmbH KGaA's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
H&R GmbH KGaA 12-1 Month Momentum % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, H&R GmbH KGaA's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where H&R GmbH KGaA's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H&R GmbH KGaA (LTS:0RRC) has a 12-1 Month Momentum % of 18.79% as of Sep. 11, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on H&R GmbH KGaA and its competitors. According to the industry distribution chart, H&R GmbH KGaA ranks #448 out of 1617 companies in the Chemicals industry, placing it in the top 27.7%.
Is H&R GmbH KGaA's 12-1 Month Momentum % too high?
H&R GmbH KGaA's current 12-1 Month Momentum % is 18.79%. The Chemicals industry median 12-1 Month Momentum % is 0.32. H&R GmbH KGaA's value of 18.79% is 5771.9% above this industry median. Based on the distribution chart, H&R GmbH KGaA ranks #448 out of 1617 companies in the Chemicals industry, which is above the industry midpoint. Overall, H&R GmbH KGaA has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does H&R GmbH KGaA's 12-1 Month Momentum % compare to LIN and SHW?
According to the Chemicals industry distribution chart, H&R GmbH KGaA ranks #448 out of 1617 companies for 12-1 Month Momentum %. This puts H&R GmbH KGaA in the upper half of its industry. The industry median 12-1 Month Momentum % is 0.32. H&R GmbH KGaA's value of 18.79% is 5771.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Chemicals company?
The median 12-1 Month Momentum % among Chemicals companies is 0.32, based on 1,617 companies in the industry. Companies in the top quartile (top 25%) have a 12-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. H&R GmbH KGaA's current 12-1 Month Momentum % of 18.79% is 5771.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on H&R GmbH KGaA and its competitors. For the Chemicals industry, the median 12-1 Month Momentum % is 0.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. H&R GmbH KGaA's current 12-1 Month Momentum % is 18.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H&R GmbH KGaA stock overvalued right now?
Based on GuruFocus' analysis, H&R GmbH KGaA (LTS:0RRC) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.79, compared to a current price of €7.18 — trading 49.9% above its estimated fair value. The current 12-1 Month Momentum % is 18.79% and 5771.9% above the Chemicals industry median of 0.32. H&R GmbH KGaA's overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For H&R GmbH KGaA (LTS:0RRC), the current 12-1 Month Momentum % is 18.79% as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is H&R GmbH KGaA (LTS:0RRC) Overvalued in 2026?
Based on GuruFocus' analysis, H&R GmbH KGaA stock appears to be overvalued.
The current stock price of €7.18 is trading 49.9% above its estimated GF Value™ of €4.79.
GuruFocus considers H&R GmbH KGaA to be Significantly Overvalued.
Key valuation signals for LTS:0RRC:
12-1 Month Momentum %: 18.79%
GF Value™: €4.79 vs. price of €7.18 (49.9% above fair value)
Industry Position: 5771.9% above the Chemicals median (#448 of 1617)
No single metric tells the full story. See the LTS:0RRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
H&R GmbH & Co KGaA is a manufacturer of chemical-pharmaceutical specialty products. The company organizes its operating activities into two business divisions: Chemical-Pharmaceutical Raw Materials and Plastics. It also has three business segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment produces specialty products from crude oil in the two domestic refineries (Hamburg-Neuhof and Salzbergen). Its ChemPharm Sales segment encompasses the production sites abroad as well as international sales activities. The company's Plastics segment manufactures high-precision plastic parts along with the associated tools and molds. The company derives a majority of its revenue from the ChemPharm Refining segment. Geographically, it derives key revenue from Germany.
62GF Score
Get the complete analysis for LTS:0RRC
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RRC has been successfully added to your 
